Skip to main content

Table 7 Selected cardiovascular adverse events during drug administration

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Adverse events

High BNP group

Extra-high BNP group

 

Dobutamine (n = 30)

rhBNP (n = 28)

P value

Dobutamine (n = 23)

rhBNP (n = 24)

P value

Symptomatic hypotension

0

0

1.000

0

1

1.000

Asymptomatic hypotension

0

2

0.229

0

3

0.234

Sustained VT

0

0

1.000

0

0

1.000

Nonsustained VT

2

0

0.492

2

1

0.609

VF

0

0

1.000

0

0

1.000

Sudden death

0

0

1.000

0

0

1.000

Cardiac arrest

0

0

1.000

0

0

1.000

  1. Abbrevations: VF ventricular fibrillation, VT ventricular tachycardia, Other abbreviations are same as in Table 2. Fisher exact text was used.